|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/127 | |
| A61K 31/436 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Patento numeris | 3346989 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15903759.7 |
| Europos patento paraiškos padavimo data | 2015-09-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/051206 |
| Data | 2015-09-21 |
| (87) | Numeris | WO 2017/044135 |
| Data | 2017-03-16 |
| (30) | Numeris | Data | Šalis |
| 201514849100 | 2015-09-09 | US |
| (72) |
SHI, Zhiwei, US
SU, Shih-horng, US
YU, Ting-bin, US
|
| (73) |
Manli International Ltd.,
39 Chuan Walk, 558445 Singapore,
SG
|
| (54) | STABLE LIPOSOMAL FORMULATIONS OF RAPAMYCIN AND RAPAMYCIN DERIVATIVES FOR TREATING CANCER |
| STABLE LIPOSOMAL FORMULATIONS OF RAPAMYCIN AND RAPAMYCIN DERIVATIVES FOR TREATING CANCER |